The global liquid biopsy market, poised for significant growth, benefits from increased demand for non-invasive cancer ...

The market for minimally invasive biopsy techniques is driven by growing cancer prevalence, patient preference for less ...

The rise in chronic diseases, especially cancer, fuels demand for early, non-invasive diagnostics offered by EV-based liquid biopsies. Key growth opportunities lie in the development of sensitive ...

The promise of scientific and medical innovation often comes with a downside: improvements in care benefit some people, but not all. Without concerted effort, that is exactly what could happen with ...

DURHAM, N.C.--(BUSINESS WIRE)--GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced the launch of its EXpressCT SM (Expression ...

Early-stage gastric cancer can be assessed more accurately using a new liquid biopsy tool that predicts lymph node metastasis ...

Liquid biopsies provide a minimally invasive approach for tumour molecular profiling, through the detection and analysis of various analytes (circulating tumour cells, cell-free DNA/circulating tumour ...

CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, today announced the expansion of its comprehensive genomic profiling offerings with xF+, a new ...

Liquid biopsy leverages circulating tumor DNA (ctDNA), exosomes, and circulating tumor cells (CTCs) to provide a non-invasive alternative for early cancer screening, recurrence monitoring, and ...

Discusses New Strategy and Business Plan Focused on Commercialization and Liquid Biopsy Innovation November 26, 2025 9:00 ...

Cancer patients often have to endure months of anxiety and side effects before they can schedule a scan or painful biopsy to learn if their treatment is working. Liquid biopsy tests, which have won ...